Selected research
Industry Research
Inhalation Anesthesia Industry Research Report 2026
Market perspective
The global Inhalation Anesthesia market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Inhalation Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Inhalation Anesthesia is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Inhalation Anesthesia is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Inhalation Anesthesia include Lunan Pharmaceutical Group Co.Ltd., Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi Ag, Baxter, AbbVie Inc., Piramal Enterprises Limited, Hikma Pharmaceuticals PLC and Halocarbon Products Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Inhalation Anesthesia market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Inhalation Anesthesia Market by Company
Lunan Pharmaceutical Group Co.Ltd.
Jiangsu Hengrui Medicine Co. Ltd.
Fresenius Kabi Ag
Baxter
AbbVie Inc.
Piramal Enterprises Limited
Hikma Pharmaceuticals PLC
Halocarbon Products Corporation
Inhalation Anesthesia Segment by Type
Isoflurane
Sevoflurane
Desflurane
Inhalation Anesthesia Segment by Application
Induction
Maintenance
Inhalation Anesthesia Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Anesthesia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Inhalation Anesthesia and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Anesthesia.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Inhalation Anesthesia manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Inhalation Anesthesia by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Inhalation Anesthesia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Isoflurane
- Sevoflurane
- Desflurane
Applications
- Induction
- Maintenance
Companies covered
- Lunan Pharmaceutical Group Co.Ltd.
- Jiangsu Hengrui Medicine Co. Ltd.
- Fresenius Kabi Ag
- Baxter
- AbbVie Inc.
- Piramal Enterprises Limited
- Hikma Pharmaceuticals PLC
- Halocarbon Products Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Inhalation Anesthesia Market Size (2021-2032)
- 2.2.2 Global Inhalation Anesthesia Sales (2021-2032)
- 2.2.3 Global Inhalation Anesthesia Market Average Price (2021-2032)
- 2.3 Inhalation Anesthesia by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Isoflurane
- 2.3.3 Sevoflurane
- 2.3.4 Desflurane
- 2.4 Inhalation Anesthesia by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Induction
- 2.4.3 Maintenance
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Inhalation Anesthesia Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Inhalation Anesthesia Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Inhalation Anesthesia Revenue of Manufacturers (2021-2026)
- 3.4 Global Inhalation Anesthesia Average Price by Manufacturers (2021-2026)
- 3.5 Global Inhalation Anesthesia Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Inhalation Anesthesia, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Inhalation Anesthesia, Product Type & Application
- 3.8 Global Manufacturers of Inhalation Anesthesia, Established Date
- 3.9 Global Inhalation Anesthesia Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Lunan Pharmaceutical Group Co.Ltd.
- 4.1.1 Lunan Pharmaceutical Group Co.Ltd. Company Information
- 4.1.2 Lunan Pharmaceutical Group Co.Ltd. Business Overview
- 4.1.3 Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Product Portfolio
- 4.1.5 Lunan Pharmaceutical Group Co.Ltd. Recent Developments
- 4.2 Jiangsu Hengrui Medicine Co. Ltd.
- 4.2.1 Jiangsu Hengrui Medicine Co. Ltd. Company Information
- 4.2.2 Jiangsu Hengrui Medicine Co. Ltd. Business Overview
- 4.2.3 Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Product Portfolio
- 4.2.5 Jiangsu Hengrui Medicine Co. Ltd. Recent Developments
- 4.3 Fresenius Kabi Ag
- 4.3.1 Fresenius Kabi Ag Company Information
- 4.3.2 Fresenius Kabi Ag Business Overview
- 4.3.3 Fresenius Kabi Ag Inhalation Anesthesia Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Kabi Ag Inhalation Anesthesia Product Portfolio
- 4.3.5 Fresenius Kabi Ag Recent Developments
- 4.4 Baxter
- 4.4.1 Baxter Company Information
- 4.4.2 Baxter Business Overview
- 4.4.3 Baxter Inhalation Anesthesia Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Baxter Inhalation Anesthesia Product Portfolio
- 4.4.5 Baxter Recent Developments
- 4.5 AbbVie Inc.
- 4.5.1 AbbVie Inc. Company Information
- 4.5.2 AbbVie Inc. Business Overview
- 4.5.3 AbbVie Inc. Inhalation Anesthesia Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AbbVie Inc. Inhalation Anesthesia Product Portfolio
- 4.5.5 AbbVie Inc. Recent Developments
- 4.6 Piramal Enterprises Limited
- 4.6.1 Piramal Enterprises Limited Company Information
- 4.6.2 Piramal Enterprises Limited Business Overview
- 4.6.3 Piramal Enterprises Limited Inhalation Anesthesia Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Piramal Enterprises Limited Inhalation Anesthesia Product Portfolio
- 4.6.5 Piramal Enterprises Limited Recent Developments
- 4.7 Hikma Pharmaceuticals PLC
- 4.7.1 Hikma Pharmaceuticals PLC Company Information
- 4.7.2 Hikma Pharmaceuticals PLC Business Overview
- 4.7.3 Hikma Pharmaceuticals PLC Inhalation Anesthesia Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hikma Pharmaceuticals PLC Inhalation Anesthesia Product Portfolio
- 4.7.5 Hikma Pharmaceuticals PLC Recent Developments
- 4.8 Halocarbon Products Corporation
- 4.8.1 Halocarbon Products Corporation Company Information
- 4.8.2 Halocarbon Products Corporation Business Overview
- 4.8.3 Halocarbon Products Corporation Inhalation Anesthesia Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Halocarbon Products Corporation Inhalation Anesthesia Product Portfolio
- 4.8.5 Halocarbon Products Corporation Recent Developments
5 Global Inhalation Anesthesia Market Scenario by Region
- 5.1 Global Inhalation Anesthesia Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Inhalation Anesthesia Sales by Region: 2021-2032
- 5.2.1 Global Inhalation Anesthesia Sales by Region: 2021-2026
- 5.2.2 Global Inhalation Anesthesia Sales by Region: 2027-2032
- 5.3 Global Inhalation Anesthesia Revenue by Region: 2021-2032
- 5.3.1 Global Inhalation Anesthesia Revenue by Region: 2021-2026
- 5.3.2 Global Inhalation Anesthesia Revenue by Region: 2027-2032
- 5.4 North America Inhalation Anesthesia Market Facts & Figures by Country
- 5.4.1 North America Inhalation Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Inhalation Anesthesia Sales by Country (2021-2032)
- 5.4.3 North America Inhalation Anesthesia Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Inhalation Anesthesia Market Facts & Figures by Country
- 5.5.1 Europe Inhalation Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Inhalation Anesthesia Sales by Country (2021-2032)
- 5.5.3 Europe Inhalation Anesthesia Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Inhalation Anesthesia Market Facts & Figures by Country
- 5.6.1 Asia Pacific Inhalation Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Inhalation Anesthesia Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Inhalation Anesthesia Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Inhalation Anesthesia Market Facts & Figures by Country
- 5.7.1 South America Inhalation Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Inhalation Anesthesia Sales by Country (2021-2032)
- 5.7.3 South America Inhalation Anesthesia Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Inhalation Anesthesia Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Inhalation Anesthesia Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Inhalation Anesthesia Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Inhalation Anesthesia Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Inhalation Anesthesia Sales by Type (2021-2032)
- 6.1.1 Global Inhalation Anesthesia Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Inhalation Anesthesia Sales Market Share by Type (2021-2032)
- 6.2 Global Inhalation Anesthesia Revenue by Type (2021-2032)
- 6.2.1 Global Inhalation Anesthesia Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Inhalation Anesthesia Revenue Market Share by Type (2021-2032)
- 6.3 Global Inhalation Anesthesia Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Inhalation Anesthesia Sales by Application (2021-2032)
- 7.1.1 Global Inhalation Anesthesia Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Inhalation Anesthesia Sales Market Share by Application (2021-2032)
- 7.2 Global Inhalation Anesthesia Revenue by Application (2021-2032)
- 7.2.1 Global Inhalation Anesthesia Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Inhalation Anesthesia Revenue Market Share by Application (2021-2032)
- 7.3 Global Inhalation Anesthesia Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Inhalation Anesthesia Value Chain Analysis
- 8.1.1 Inhalation Anesthesia Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Inhalation Anesthesia Production Mode & Process
- 8.2 Inhalation Anesthesia Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Inhalation Anesthesia Distributors
- 8.2.3 Inhalation Anesthesia Customers
9 Global Inhalation Anesthesia Analyzing Market Dynamics
- 9.1 Inhalation Anesthesia Industry Trends
- 9.2 Inhalation Anesthesia Industry Drivers
- 9.3 Inhalation Anesthesia Industry Opportunities and Challenges
- 9.4 Inhalation Anesthesia Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst